[Remote] Business Development Director, MRD Strategy at Tempus

Illinois, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Biotechnology, Pharmaceuticals, Medical DevicesIndustries

Skills

Key technologies and capabilities for this role

Business DevelopmentSales StrategyMinimal Residual Disease (MRD)OncologyHealthcare IndustryPrecision MedicineSales ManagementMarket ExpansionCross-functional Collaboration

Questions & Answers

Common questions about this position

What is the employment type for this position?

This is a full-time position.

Is this role remote or does it require office presence?

This information is not specified in the job description.

What are the key responsibilities for the Business Development Director, MRD Strategy?

The role involves leading and driving the MRD sales strategy, managing business results and strategic collaborations, developing business plans, maintaining key customer relationships, and overseeing CRM management for the MRD team.

What is the company culture like at Tempus?

Tempus focuses on advancing precision medicine and healthcare through AI, emphasizing passion for the industry, cross-functional collaboration, alignment with strategic objectives and organizational values, and establishing leadership in MRD testing.

What makes a strong candidate for this Business Development Director role?

A strong candidate will have deep industry expertise in oncology and MRD, experience building scalable sales strategies, analytical rigor for problem-solving, and skills in managing teams, CRM systems, and key customer relationships in academic medical centers and cancer centers.

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters

2015Year Founded

$894.9MTotal Funding

IPOCompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Relocation Assistance

Company Equity

Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.

Ambry Genetics acquisition could pose financial risks if synergies aren't realized.

Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.

Their platform aids in personalized treatment decisions for cancer patients.

Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.

Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.

Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI

Try Jobo Free